Judge Allows Ariad To Appeal Enbrel Case
A federal magistrate judge has allowed Ariad Pharmaceuticals Inc. to appeal immediately an earlier decision that rival Amgen Inc. did not infringe its patent related to an arthritis drug....To view the full article, register now.
Already a subscriber? Click here to view full article